Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma

NCT07174427 is registered in ClinicalTrials.gov with Takara Bio Inc. as lead sponsor.

NCT NCT07174427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Lead sponsor
Takara Bio Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
January 5, 2026
Completion date
March 31, 2032
Enrollment
5 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

synovial sarcomas